Replies to post #97461 on Biotech Values

[DewDiligence]

Sprycel gets FDA priority review for first-line CML, which is notable insofar as Tasigna is now approved in this indication (#msg-51437844):

http://finance.yahoo.com/news/SPRYCEL-dasatinib-Receives-bw-1253115545.html?x=0&.v=1

The PDUFA date is 10/28/10.

[DewDiligence]

EU’s CHMP approves NVS’ Tasigna for first-line CML:

http://www.novartis.com/newsroom/media-releases/en/2010/1446754.shtml

FDA approval of Tasigna for first-line CML occurred in Jun 2010 (#msg-51437844). BMY’s Spycel has a 10/28/10 PDUFA date for the same indication.